These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 2863915)
21. Growth hormone and somatomedin-C response to synthetic human pancreatic tumor GH-releasing factor in hypopituitary and constitutionally short children. Minuto F; Barreca A; Del Monte P; Mauri R; Resentini M; Fortini P; Morabito M; Giordano G J Endocrinol Invest; 1986 Dec; 9(6):447-52. PubMed ID: 3106458 [TBL] [Abstract][Full Text] [Related]
22. Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. Intermittent secretion or response attenuation. Webb CB; Vance ML; Thorner MO; Perisutti G; Thominet J; Rivier J; Vale W; Frohman LA J Clin Invest; 1984 Jul; 74(1):96-103. PubMed ID: 6429198 [TBL] [Abstract][Full Text] [Related]
23. Dual effects of growth hormone (GH)-releasing hormone infusion in normal men: somatotroph desensitization and increase in releasable GH. Vance ML; Kaiser DL; Rivier J; Vale W; Thorner MO J Clin Endocrinol Metab; 1986 Mar; 62(3):591-4. PubMed ID: 3080467 [TBL] [Abstract][Full Text] [Related]
25. Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy. Vance ML; Kaiser DL; Martha PM; Furlanetto R; Rivier J; Vale W; Thorner MO J Clin Endocrinol Metab; 1989 Jan; 68(1):22-8. PubMed ID: 2491864 [TBL] [Abstract][Full Text] [Related]
26. Testing with growth hormone-releasing factor (GRF(1-29)NH2) and somatomedin C measurements for the evaluation of growth hormone deficiency. Ranke MB; Gruhler M; Rosskamp R; Brügmann G; Attanasio A; Blum WF; Bierich JR Eur J Pediatr; 1986 Dec; 145(6):485-92. PubMed ID: 2880720 [TBL] [Abstract][Full Text] [Related]
27. Pituitary growth hormone response in rats during a 24-hour infusion of growth hormone-releasing factor. Wehrenberg WB; Brazeau P; Ling N; Textor G; Guillemin R Endocrinology; 1984 May; 114(5):1613-6. PubMed ID: 6143658 [TBL] [Abstract][Full Text] [Related]
28. Plasma growth hormone (GH) responses to single and repetitive subcutaneous administration of GH releasing factor (hpGRF-44) in normal and GH deficient children. Takano K; Hizuka N; Shizume K; Honda N; Ling NC Acta Endocrinol (Copenh); 1985 Jan; 108(1):11-9. PubMed ID: 3918397 [TBL] [Abstract][Full Text] [Related]
29. Restoration of juvenile baseline growth hormone secretion with preservation of the ultradian growth hormone rhythm by continuous delivery of growth hormone-releasing factor. Vasilatos-Younken R; Tsao PH; Foster DN; Smiley DL; Bryant H; Heiman ML J Endocrinol; 1992 Nov; 135(2):371-82. PubMed ID: 1474343 [TBL] [Abstract][Full Text] [Related]
30. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion. Kelijman M; Frohman LA J Clin Endocrinol Metab; 1990 Jul; 71(1):157-63. PubMed ID: 1973420 [TBL] [Abstract][Full Text] [Related]
31. Results of 1-year growth hormone (GH)-releasing hormone-(1-44) treatment on growth, somatomedin-C, and 24-hour GH secretion in six children with partial GH deficiency. Rochiccioli PE; Tauber MT; Coude FX; Arnone M; Morre M; Uboldi F; Barbeau C J Clin Endocrinol Metab; 1987 Aug; 65(2):268-74. PubMed ID: 3110202 [TBL] [Abstract][Full Text] [Related]
32. Human growth hormone-releasing hormone (hGH-RH; hGRF) treatment of four patients with GH deficiency. Takano K; Hizuka N; Asakawa K; Chihara K; Sanayama K; Shizume K Endocrinol Jpn; 1988 Oct; 35(5):775-81. PubMed ID: 3146502 [TBL] [Abstract][Full Text] [Related]
33. The effect of pulsatile administration, continuous infusion, and diurnal variation on the growth hormone (GH) response to GH-releasing hormone in normal men. Hulse JA; Rosenthal SM; Cuttler L; Kaplan SL; Grumbach MM J Clin Endocrinol Metab; 1986 Oct; 63(4):872-8. PubMed ID: 3091629 [TBL] [Abstract][Full Text] [Related]
34. Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men. Jaffe CA; Ho PJ; Demott-Friberg R; Bowers CY; Barkan AL J Clin Endocrinol Metab; 1993 Dec; 77(6):1641-7. PubMed ID: 7903313 [TBL] [Abstract][Full Text] [Related]